Method of treatment of amyotrophic lateral sclerosis with a...

Details Method of treatment of amyotrophic lateral sclerosis with a... Method of treatment of amyotrophic lateral sclerosis with a...

2005-02-15

2005-02-15

Carlson, Karen Cochrane (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000, C424S185100

Reexamination Certificate

active

06855694

ABSTRACT:
A method of treatment of patients affected by amyotrophic lateral sclerosis comprising the administration of an effective amount of a 14 kDa protein extractable from mammalian organs, particularly mammalian liver.

REFERENCES:
patent: 92 10197 (1992-06-01), None
patent: 98 11909 (1998-03-01), None
patent: 98 42366 (1998-10-01), None
Panerai et al; “Chronic Administration of UK-114, A Multifunctional Emerging Protein, Modulates the Th1/th2 Cytokine Pattern and Experimental Autoimmune Diseases”; Annals of the New York Academy of Sciences, Jun. 22, 1999, 876 229-35, XP000971426.

Affiliated with

Also associated with

Rating

Method of treatment of amyotrophic lateral sclerosis with a... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment of amyotrophic lateral sclerosis with a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of amyotrophic lateral sclerosis with a... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3483739